HALOZYME THERAPEUTICS, INC. - COM (HALO)

Q2 2017 13F Holders as of 6/30/2017

Type / Class
Equity / COM
Number of holders
165
Total Shares
122M
Shares change
+6.97M
Total reported value, excl. options
$1.56B
Value change
+$89.2M
Put/Call ratio
0.12
Number of buys
100
Number of sells
-54
Price
$12.82
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.